|
Real-time Estimate
Tradegate
01:30:15 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 38.90 EUR | +0.26% |
|
-0.51% | -4.90% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 08-25 | Sanofi : Deutsche Bank reiterates its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,060B | |||||
| 651B | - | - | - | ||
| 465B | |||||
| 365B | |||||
| 300B |
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
- Charts Sanofi
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
